{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:20:45Z","timestamp":1791991245652,"version":"4.4.0"},"reference-count":226,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:p>This review focuses on discussing the main modifications of the recently published 2017 WHO Classification of Neoplasms of the Neuroendocrine Pancreas (panNEN). Recent updates separate pancreatic neuroendocrine tumors into 2 broad categories: well-differentiated pancreatic neuroendocrine tumors (panNET) and poorly differentiated pancreatic neuroendocrine carcinoma (panNEC), and incorporates a new subcategory of \u201cwell-differentiated high-grade NET (G3)\u201d to the well-differentiated NET category. This new classification algorithm aims to improve the prediction of clinical outcomes and survival and help clinicians select better therapeutic strategies for patient care and management. In addition, these neuroendocrine neoplasms are capable of producing large quantity of hormones leading to clinical hormone hypersecretion syndromes. These functioning tumors include, insulinomas, glucagonomas, somatostatinomas, gastrinomas, VIPomas, serotonin-producing tumors, and ACTH-producing tumors. Although most panNENs arise as sporadic diseases, a subset of these heterogeneous tumors present as parts on inherited genetic syndromes, such as multiple endocrine neoplasia type 1, von Hippel-Lindau, neurofibromatosis type 1, tuberous sclerosis, and glucagon cell hyperplasia and neoplasia syndromes. Characteristic clinical and morphologic findings for certain functioning and syndromic panNENs should alert both pathologists and clinicians as appropriate patient management and possible genetic counseling may be necessary.<\/jats:p>","DOI":"10.1097\/pap.0000000000000201","type":"journal-article","created":{"date-parts":[[2018,6,14]],"date-time":"2018-06-14T23:21:32Z","timestamp":1529018492000},"page":"13-30","source":"Crossref","is-referenced-by-count":100,"title":["Neoplasms of the Neuroendocrine Pancreas: An Update in the Classification, Definition, and Molecular Genetic Advances"],"prefix":"10.1097","volume":"26","author":[{"given":"Julie M.","family":"Guilmette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vania","family":"Nos\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"suppl 2","key":"R1-20230921","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1038\/modpathol.2010.127","article-title":"Pancreatic endocrine tumors","volume":"24","author":"Asa","year":"2011","journal-title":"Mod Pathol"},{"key":"R2-20230921","first-page":"258","article-title":"Update on pancreatic neuroendocrine tumors","volume":"3","author":"McKenna","year":"2014","journal-title":"Gland Surg"},{"key":"R3-20230921","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.soc.2015.12.003","article-title":"Clinical presentation and diagnosis of pancreatic neuroendocrine tumors","volume":"25","author":"Anderson","year":"2016","journal-title":"Surg Oncol Clin N Am"},{"key":"R4-20230921","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.bpg.2013.01.006","article-title":"Epidemiology of gastroenteropancreatic neuroendocrine tumours","volume":"26","author":"Fraenkel","year":"2012","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R5-20230921","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ecl.2010.12.005","article-title":"The epidemiology of gastroenteropancreatic neuroendocrine tumors","volume":"40","author":"Lawrence","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R6-20230921","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s12262-015-1360-2","article-title":"Pancreatic neuroendocrine tumors: an update","volume":"77","author":"Paniccia","year":"2015","journal-title":"Indian J Surg"},{"key":"R7-20230921","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11864-011-0172-2","article-title":"Neuroendocrine pancreatic tumors: guidelines for management and update","volume":"13","author":"Burns","year":"2012","journal-title":"Curr Treat Options Oncol"},{"key":"R8-20230921","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.hoc.2010.06.008","article-title":"Endocrine cancer predisposition syndromes: hereditary paraganglioma, multiple endocrine neoplasia type 1, multiple endocrine neoplasia type 2, and hereditary thyroid cancer","volume":"24","author":"Rubinstein","year":"2010","journal-title":"Hematol Oncol Clin North Am"},{"key":"R9-20230921","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1053\/j.seminoncol.2010.10.014","article-title":"Pancreatic endocrine tumors","volume":"37","author":"Oberg","year":"2010","journal-title":"Semin Oncol"},{"key":"R11-20230921","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/jhbp.208","article-title":"Pathology diagnosis of pancreatic neuroendocrine tumors","volume":"22","author":"Kasajima","year":"2015","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"R12-20230921","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/PAS.0000000000000408","article-title":"The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms","volume":"39","author":"Basturk","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R13-20230921","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1530\/ERC-15-0119","article-title":"Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms","volume":"22","author":"Heetfeld","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"R14-20230921","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ctrv.2016.08.006","article-title":"Heterogeneity of grade 3 gastroenteropancreatic neuroendocrine carcinomas: new insights and treatment implications","volume":"50","author":"Fazio","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"R15-20230921","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1530\/ERC-13-0027","article-title":"Are G3 ENETS neuroendocrine neoplasms heterogeneous?","volume":"20","author":"V\u00e9layoudom-C\u00e9phise","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"R16-20230921","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1158\/1078-0432.CCR-15-0548","article-title":"Well-differentiated neuroendocrine tumors with a morphologically apparent high-grade component: a pathway distinct from poorly differentiated neuroendocrine carcinomas","volume":"22","author":"Tang","year":"2016","journal-title":"Clin Cancer Res"},{"key":"R17-20230921","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000443172","article-title":"ENETS consensus guidelines for high-grade gastroenteropancreatic neuroendocrine tumors and neuroendocrine carcinomas","volume":"103","author":"Garcia-Carbonero","year":"2016","journal-title":"Neuroendocrinology"},{"key":"R18-20230921","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000442207","article-title":"Trends in incidence of neuroendocrine neoplasms in Norway: a report of 16,075 cases from 1993 through 2010","volume":"104","author":"Cetinkaya","year":"2016","journal-title":"Neuroendocrinology"},{"key":"R19-20230921","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s11605-009-1115-0","article-title":"Non-functional neuroendocrine carcinoma of the pancreas: incidence, tumor biology, and outcomes in 2,158 patients","volume":"14","author":"Franko","year":"2010","journal-title":"J Gastrointest Surg"},{"key":"R20-20230921","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature21063","article-title":"Whole-genome landscape of pancreatic neuroendocrine tumours","volume":"543","author":"Scarpa","year":"2017","journal-title":"Nature"},{"key":"R21-20230921","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00000478-198408000-00004","article-title":"Immunohistochemical detection of chromogranin and neuron-specific enolase in pancreatic endocrine neoplasms","volume":"8","author":"Lloyd","year":"1984","journal-title":"Am J Surg Pathol"},{"key":"R22-20230921","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1053\/j.semdp.2014.08.008","article-title":"Pancreatic neuroendocrine tumors: pathologic and molecular characteristics","volume":"31","author":"Shi","year":"2014","journal-title":"Semin Diagn Pathol"},{"key":"R23-20230921","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/bjc.1998.635","article-title":"Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours","volume":"78","author":"Baudin","year":"1998","journal-title":"Br J Cancer"},{"key":"R24-20230921","first-page":"23","article-title":"Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours","volume":"58","author":"Kasprzak","year":"2007","journal-title":"Pol J Pathol"},{"key":"R25-20230921","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0344-0338(88)80043-8","article-title":"Pancreatic endocrine tumors","volume":"183","author":"Kl\u00f6ppel","year":"1988","journal-title":"Pathol Res Pract"},{"key":"R26-20230921","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/PAS.0000000000000662","article-title":"A practical approach to the classification of WHO Grade 3 (G3) well-differentiated neuroendocrine tumor (WD-NET) and poorly differentiated neuroendocrine carcinoma (PD-NEC) of the pancreas","volume":"40","author":"Tang","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R27-20230921","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5582\/irdr.2017.01007","article-title":"Pancreatic neuroendocrine tumors","volume":"6","author":"Sun","year":"2017","journal-title":"Intractable Rare Dis Res"},{"key":"R28-20230921","first-page":"1","article-title":"DAXX\/ATRX and MEN1 genes are strong prognostic markers in pancreatic neuroendocrine tumors","volume":"1","author":"Park","year":"2017","journal-title":"Oncotarget"},{"key":"R29-20230921","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1586\/17474124.2015.1092383","article-title":"Genetics of pancreatic neuroendocrine tumors: implications for the clinic","volume":"9","author":"Pea","year":"2015","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"R30-20230921","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.3390\/ijms18010143","article-title":"Pancreatic neuroendocrine neoplasms: basic biology, current treatment strategies and prospects for the future","volume":"18","author":"Ohmoto","year":"2017","journal-title":"Int J Mol Sci"},{"key":"R31-20230921","doi-asserted-by":"crossref","first-page":"E2404","DOI":"10.1073\/pnas.1319962111","article-title":"PHLDA3 is a novel tumor suppressor of pancreatic neuroendocrine tumors","volume":"111","author":"Ohki","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R32-20230921","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/cas.13235","article-title":"A vicious partnership between AKT and PHLDA3 to facilitate neuroendocrine tumors","volume":"108","author":"Takikawa","year":"2017","journal-title":"Cancer Sci"},{"key":"R33-20230921","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1053\/j.gastro.2013.10.020","article-title":"Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors","volume":"146","author":"Marinoni","year":"2014","journal-title":"Gastroenterology"},{"key":"R34-20230921","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/modpathol.2012.53","article-title":"Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors","volume":"25","author":"De Wilde","year":"2012","journal-title":"Mod Pathol"},{"key":"R35-20230921","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1126\/science.1200609","article-title":"DAXX\/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors","volume":"331","author":"Jiao","year":"2011","journal-title":"Science"},{"key":"R36-20230921","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1200\/JCO.2008.21.5988","article-title":"Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway","volume":"28","author":"Missiaglia","year":"2010","journal-title":"J Clin Oncol"},{"key":"R37-20230921","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0002-9440(10)64624-X","article-title":"Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells","volume":"157","author":"Perren","year":"2000","journal-title":"Am J Pathol"},{"key":"R38-20230921","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.7150\/ijbs.16233","article-title":"Genes involved in angiogenesis and mTOR pathways are frequently mutated in Asian patients with pancreatic neuroendocrine tumors","volume":"12","author":"Chou","year":"2016","journal-title":"Int J Biol Sci"},{"key":"R39-20230921","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1756-8722-4-29","article-title":"Evolving diagnostic and treatment strategies for pancreatic neuroendocrine tumors","volume":"4","author":"Kulke","year":"2011","journal-title":"J Hematol Oncol"},{"key":"R40-20230921","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2013.02.016","article-title":"PI3K\/Akt\/mTOR pathway inhibitors in the therapy of pancreatic neuroendocrine tumors","volume":"335","author":"Wolin","year":"2013","journal-title":"Cancer Lett"},{"key":"R41-20230921","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11523-012-0220-2","article-title":"Sunitinib in pancreatic neuroendocrine tumors","volume":"7","author":"Raymond","year":"2012","journal-title":"Target Oncol"},{"key":"R42-20230921","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000329386","article-title":"From targets to treatments: a review of molecular targets in pancreatic neuroendocrine tumors","volume":"94","author":"Wiedenmann","year":"2011","journal-title":"Neuroendocrinology"},{"key":"R43-20230921","doi-asserted-by":"crossref","first-page":"537","DOI":"10.5946\/ce.2017.131","article-title":"Diagnosis of pancreatic neuroendocrine tumors","volume":"50","author":"Lee","year":"2017","journal-title":"Clin Endosc"},{"key":"R44-20230921","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1053\/j.gastro.2008.05.047","article-title":"Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors","volume":"135","author":"Metz","year":"2008","journal-title":"Gastroenterology"},{"key":"R45-20230921","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nrgastro.2012.9","article-title":"Well-differentiated pancreatic neuroendocrine tumors: from genetics to therapy","volume":"9","author":"De Wilde","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R46-20230921","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/jhbp.224","article-title":"Determinants of surgical resection for pancreatic neuroendocrine tumors","volume":"22","author":"Doi","year":"2015","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"R47-20230921","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3748\/wjg.v19.i6.829","article-title":"Diagnosis and management of insulinoma","volume":"19","author":"Okabayashi","year":"2013","journal-title":"World J Gastroenterol"},{"key":"R48-20230921","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1210\/jc.2015-2914","article-title":"Histologic and molecular profile of pediatric insulinomas: evidence of a paternal parent-of-origin effect","volume":"101","author":"Bhatti","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"R49-20230921","doi-asserted-by":"crossref","first-page":"484","DOI":"10.4149\/neo_2015_058","article-title":"Prognostic validation of the WHO 2010 grading system in pancreatic insulinoma patients","volume":"62","author":"Wang","year":"2015","journal-title":"Neoplasma"},{"issue":"suppl 1","key":"R50-20230921","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1530\/ERC-11-0013","article-title":"Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms","volume":"18","author":"Kl\u00f6ppel","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"R51-20230921","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000335587","article-title":"ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors","volume":"95","author":"Falconi","year":"2012","journal-title":"Neuroendocrinology"},{"key":"R52-20230921","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1245\/s10434-007-9566-6","article-title":"Population-based study of islet cell carcinoma","volume":"14","author":"Yao","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"R53-20230921","first-page":"2749","article-title":"Glucagonoma and the glucagonoma syndrome","volume":"15","author":"Song","year":"2018","journal-title":"Oncol Lett"},{"key":"R54-20230921","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s11606-013-2490-5","article-title":"Putting the pieces together: necrolytic migratory erythema and the glucagonoma syndrome","volume":"28","author":"Halvorson","year":"2013","journal-title":"J Gen Intern Med"},{"key":"R55-20230921","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00005792-199603000-00002","article-title":"The glucagonoma syndrome. Clinical and pathologic features in 21 patients","volume":"75","author":"Wermers","year":"1996","journal-title":"Medicine (Baltimore)"},{"key":"R56-20230921","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00000441-200105000-00003","article-title":"The glucagonoma syndrome: a review of its features and discussion of new perspectives","volume":"321","author":"Chastain","year":"2001","journal-title":"Am J Med Sci"},{"key":"R57-20230921","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2265.2011.03967.x","article-title":"Glucagonoma and the glucagonoma syndrome\u2014cumulative experience with an elusive endocrine tumour","volume":"74","author":"Eldor","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R58-20230921","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1530\/eje.0.1510531","article-title":"The glucagonoma syndrome and necrolytic migratory erythema: a clinical review","volume":"151","author":"van Beek","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"R59-20230921","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0033-3182(09)70850-3","article-title":"Glucagonoma-associated neuropsychiatric and affective symptoms: diagnostic dilemmas raised by paraneoplastic phenomena","volume":"50","author":"McGevna","year":"2009","journal-title":"Psychosomatics"},{"key":"R60-20230921","first-page":"483","article-title":"Pancreatic glucagonoma and deep vein thrombosis","volume":"21","author":"Guilarte Lopez-Manas","year":"1998","journal-title":"Gastroenterol Hepatol"},{"key":"R61-20230921","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1046\/j.1365-2265.2002.01660.x","article-title":"Peripheral amino acid and fatty acid infusion for the treatment of necrolytic migratory erythema in the glucagonoma syndrome","volume":"57","author":"Alexander","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R62-20230921","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0399-8320(04)95184-6","article-title":"Prevalence, characteristics and prognosis of MEN 1-associated glucagonomas, VIPomas, and somatostatinomas: study from the GTE (Groupe des Tumeurs Endocrines) registry","volume":"28","author":"L\u00e9vy-Bohbot","year":"2004","journal-title":"Gastroenterol Clin Biol"},{"key":"R63-20230921","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s12032-007-0011-2","article-title":"Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years","volume":"24","author":"Kindmark","year":"2007","journal-title":"Med Oncol"},{"key":"R64-20230921","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s005340050052","article-title":"Glucagonomas\/diabetico-dermatogenic syndrome (DDS): a statistical evaluation of 407 reported cases","volume":"5","author":"Soga","year":"1998","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"R65-20230921","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jamcollsurg.2007.05.009","article-title":"Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors","volume":"205","author":"Bilimoria","year":"2007","journal-title":"J Am Coll Surg"},{"key":"R66-20230921","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/PAS.0000000000000383","article-title":"Clinicopathologic and prognostic significance of multiple hormone expression in pancreatic neuroendocrine tumors","volume":"39","author":"Kim","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R67-20230921","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1440-1746.2007.05053.x","article-title":"Somatostatinoma: clinico-pathological features of three cases and literature reviewed","volume":"23","author":"Nesi","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"R68-20230921","doi-asserted-by":"crossref","first-page":"394","DOI":"10.4158\/EP.12.4.394","article-title":"Spectrum of malignant somatostatin-producing neuroendocrine tumors","volume":"12","author":"Moayedoddin","year":"2006","journal-title":"Endocr Pract"},{"key":"R69-20230921","doi-asserted-by":"crossref","first-page":"e1787","DOI":"10.1542\/peds.2013-2419","article-title":"Polycythemia and paraganglioma with a novel somatic HIF2A mutation in a male","volume":"133","author":"Toyoda","year":"2014","journal-title":"Pediatrics"},{"key":"R70-20230921","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00109-012-0967-z","article-title":"A novel EPAS1\/HIF2A germline mutation in a congenital polycythemia with paraganglioma","volume":"91","author":"Lorenzo","year":"2013","journal-title":"J Mol Med"},{"key":"R71-20230921","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1182\/blood-2012-10-460972","article-title":"Novel HIF2A mutations disrupt oxygen sensing, leading to polycythemia, paragangliomas, and somatostatinomas","volume":"121","author":"Yang","year":"2013","journal-title":"Blood"},{"key":"R72-20230921","doi-asserted-by":"crossref","first-page":"e396","DOI":"10.1210\/jc.2013-2600","article-title":"Mosaicism in HIF2A-related polycythemia-paraganglioma syndrome","volume":"99","author":"Buffet","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R73-20230921","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1677\/ERC-07-0157","article-title":"Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: Incidence, types, biological behavior, association with inherited syndromes, and functional activity","volume":"15","author":"Garbrecht","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"R74-20230921","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1093\/annonc\/mdi358","article-title":"Endocrine pancreatic tumors: factors correlated with survival","volume":"16","author":"Tomassetti","year":"2005","journal-title":"Ann Oncol"},{"key":"R75-20230921","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1677\/ERC-07-0221","article-title":"Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors","volume":"15","author":"Halfdanarson","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"R76-20230921","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/01.sla.0000246951.21252.60","article-title":"An aggressive surgical approach leads to long-term survival in patients with pancreatic endocrine tumors","volume":"244","author":"Fendrich","year":"2006","journal-title":"Ann Surg"},{"key":"R77-20230921","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1210\/jcem.86.11.8011","article-title":"Prospective study of the natural history of gastrinoma in patients with MEN1: definition of an aggressive and a nonaggressive form","volume":"86","author":"Gibril","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R78-20230921","first-page":"1668","article-title":"Gastrinomas associated with MEN-1 syndrome: new insights for the diagnosis and management in a series of 11 patients","volume":"52","author":"Nikou","year":"2005","journal-title":"Hepatogastroenterology"},{"key":"R79-20230921","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.3748\/wjg.v12.i34.5440","article-title":"Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features","volume":"12","author":"Anlauf","year":"2006","journal-title":"World J Gastroenterol"},{"key":"R80-20230921","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/jhbp.226","article-title":"Clinical features of pancreatic neuroendocrine tumors","volume":"22","author":"Grozinsky-Glasberg","year":"2015","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"R81-20230921","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/01.md.0000236956.74128.76","article-title":"Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the national institutes of health and comparison with 2229 cases from the literature","volume":"85","author":"Berna","year":"2006","journal-title":"Medicine (Baltimore)"},{"key":"R82-20230921","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cgh.2011.07.012","article-title":"Diagnosis of the Zollinger-Ellison syndrome","volume":"10","author":"Metz","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R83-20230921","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00005792-200011000-00004","article-title":"Zollinger-Ellison syndrome. Clinical presentation in 261 patients","volume":"79","author":"Roy","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"R84-20230921","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00005792-200105000-00005","article-title":"Gastric secretion in Zollinger-Ellison syndrome: correlation with clinical expression, tumor extent and role in diagnosis\u2014a prospective NIH study of 235 patients and a review of 984 cases in the literature","volume":"80","author":"Roy","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"R85-20230921","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1128\/MCB.00302-15","article-title":"Islet cells serve as cells of origin of pancreatic gastrin-positive endocrine tumors","volume":"35","author":"Bonnavion","year":"2015","journal-title":"Mol Cell Biol"},{"key":"R86-20230921","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1148\/rg.306105523","article-title":"Pancreatic endocrine tumors: radiologic-clinicopathologic correlation","volume":"30","author":"Lewis","year":"2010","journal-title":"Radiographics"},{"key":"R87-20230921","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0039-6109(16)44190-3","article-title":"Update on the diagnosis and treatment of rare neuroendocrine tumors","volume":"67","author":"Friesen","year":"1987","journal-title":"Surg Clin North Am"},{"key":"R88-20230921","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/0002-9343(58)90075-5","article-title":"Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia","volume":"25","author":"Verner","year":"1958","journal-title":"Am J Med"},{"key":"R89-20230921","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s11605-007-0177-0","article-title":"Pancreatic VIPomas: subject review and one institutional experience","volume":"12","author":"Ghaferi","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"R90-20230921","first-page":"1","article-title":"VIPoma syndrome: challenges in management","volume":"51","author":"Adam","year":"2010","journal-title":"Singapore Med J"},{"key":"R91-20230921","first-page":"389","article-title":"Vipoma\/diarrheogenic syndrome: a statistical evaluation of 241 reported cases","volume":"17","author":"Soga","year":"1998","journal-title":"J Exp Clin Cancer Res"},{"key":"R92-20230921","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/MPA.0b013e3181b2bc7c","article-title":"Diagnosis and treatment of pancreatic vasoactive intestinal peptide endocrine tumors","volume":"38","author":"Song","year":"2009","journal-title":"Pancreas"},{"key":"R93-20230921","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.regpep.2008.10.002","article-title":"Release of regulatory gut peptides somatostatin, neurotensin and vasoactive intestinal peptide by acid and hyperosmolal solutions in the intestine in conscious rats","volume":"152","author":"Rudholm","year":"2009","journal-title":"Regul Pept"},{"key":"R94-20230921","article-title":"Diagnosis and management of pancreatic neuroendocrine tumors (PNETS)","author":"Vinik","year":"2000","journal-title":"Endotext"},{"key":"R95-20230921","article-title":"Vasoactive intestinal peptide tumor (VIPoma)","author":"Vinik","year":"2000","journal-title":"Endotext"},{"key":"R96-20230921","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1200\/JCO.2011.35.1817","article-title":"Prognostic validity of a Novel American Joint Committee on Cancer staging classification for pancreatic neuroendocrine tumors","volume":"29","author":"Strosberg","year":"2011","journal-title":"J Clin Oncol"},{"key":"R97-20230921","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/MPA.0b013e31822041a9","article-title":"Serotonin-producing enterochromaffin cell tumors of the pancreas: clinicopathologic study of 15 cases and comparison with intestinal enterochromaffin cell tumors","volume":"40","author":"La Rosa","year":"2011","journal-title":"Pancreas"},{"key":"R98-20230921","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1159\/000201476","article-title":"Carcinoid of the pancreas","volume":"58","author":"Maurer","year":"1997","journal-title":"Digestion"},{"key":"R99-20230921","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/0959-8049(96)00049-4","article-title":"Carcinoid of the pancreas: clinical characteristics and morphological features","volume":"32","author":"Maurer","year":"1996","journal-title":"Eur J Cancer"},{"key":"R100-20230921","doi-asserted-by":"crossref","first-page":"e6201","DOI":"10.1097\/MD.0000000000006201","article-title":"Pancreatic carcinoids (serotonin-producing pancreatic neuroendocrine neoplasms): report of 5 cases and review of the literature","volume":"96","author":"Tsoukalas","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"R101-20230921","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1385\/IJGC:23:2:153","article-title":"Carcinoid tumors of the pancreas\u2014status report based on two cases and review of the world\u2019s literature","volume":"23","author":"Mao","year":"1998","journal-title":"Int J Pancreatol"},{"key":"R102-20230921","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.humpath.2011.09.014","article-title":"Serotonin expression in pancreatic neuroendocrine tumors correlates with a trabecular histologic pattern and large duct involvement","volume":"43","author":"McCall","year":"2012","journal-title":"Hum Pathol"},{"issue":"pt 1","key":"R103-20230921","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/0016-5085(88)90016-9","article-title":"Chronic pancreatitis and pseudocyst formation secondary to carcinoid tumor of the pancreas","volume":"94","author":"Gettenberg","year":"1988","journal-title":"Gastroenterology"},{"key":"R104-20230921","first-page":"97","article-title":"Pancreatic carcinoid: an unusual tumour in an uncommon location","volume":"44","author":"Prasad","year":"1998","journal-title":"J Postgr Med"},{"key":"R105-20230921","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.3892\/ol.2017.5678","article-title":"Carcinoid syndrome from a carcinoid tumor of the pancreas without liver metastases: a case report and literature review","volume":"13","author":"Zavras","year":"2017","journal-title":"Oncol Lett"},{"key":"R106-20230921","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/cncr.11105","article-title":"A 5-decade analysis of 13,715 carcinoid tumors","volume":"97","author":"Modlin","year":"2003","journal-title":"Cancer"},{"key":"R107-20230921","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/PAS.0000000000000340","article-title":"ACTH-secreting pancreatic neoplasms associated with Cushing syndrome: clinicopathologic study of 11 cases and review of the literature","volume":"39","author":"Maragliano","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R108-20230921","first-page":"46","article-title":"Metastatic pancreatic neuroendocrine tumor with ectopic adrenocorticotropic hormone production","volume":"28","author":"Vaduganathan","year":"2015","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"R109-20230921","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jamcollsurg.2004.02.031","article-title":"Adrenocorticotropic hormone-secreting pancreatic islet cell carcinoma","volume":"199","author":"Lee","year":"2004","journal-title":"J Am Coll Surg"},{"key":"R110-20230921","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF02787369","article-title":"Metastatic pancreatic neuroendocrine carcinoma causing Cushing\u2019s syndrome. ACTH secretion by metastases 3 years after resection of nonfunctioning primary cancer","volume":"19","author":"Zhu","year":"1996","journal-title":"Int J Pancreatol"},{"issue":"suppl 1","key":"R111-20230921","doi-asserted-by":"crossref","first-page":"S222","DOI":"10.1016\/j.ijsu.2014.05.035","article-title":"ACTH-secreting neuroendocrine pancreatic tumor: a case report","volume":"12","author":"Surace","year":"2014","journal-title":"Int J Surg"},{"key":"R112-20230921","first-page":"12","article-title":"Cushing\u2019s disease: a multidisciplinary overview of the clinical features, diagnosis, and treatment","volume":"9","author":"Buliman","year":"2016","journal-title":"J Med Life"},{"key":"R113-20230921","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/jclinpath-2014-202612","article-title":"Clinicopathological correlates of adrenal Cushing\u2019s syndrome","volume":"68","author":"Duan","year":"2015","journal-title":"J Clin Pathol"},{"key":"R114-20230921","first-page":"281","article-title":"Cushing\u2019s syndrome: epidemiology and developments in disease management","volume":"7","author":"Sharma","year":"2015","journal-title":"Clin Epidemiol"},{"key":"R115-20230921","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1093\/annonc\/mdn351","article-title":"Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival","volume":"19","author":"Halfdanarson","year":"2008","journal-title":"Ann Oncol"},{"key":"R116-20230921","doi-asserted-by":"crossref","first-page":"e983","DOI":"10.1097\/MD.0000000000000983","article-title":"Behavior of small, asymptomatic, nonfunctioning pancreatic neuroendocrine tumors (NF-PNETs)","volume":"94","author":"Jung","year":"2015","journal-title":"Medicine"},{"key":"R117-20230921","doi-asserted-by":"crossref","first-page":"5609","DOI":"10.1200\/JCO.2007.12.9809","article-title":"Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO classification system be simplified?","volume":"25","author":"Ferrone","year":"2007","journal-title":"J Clin Oncol"},{"key":"R118-20230921","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/jnci\/djs208","article-title":"TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study","volume":"104","author":"Rindi","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"R119-20230921","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/modpathol.2010.58","article-title":"Pancreatic endocrine tumors: Improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients","volume":"23","author":"Scarpa","year":"2010","journal-title":"Mod Pathol"},{"key":"R120-20230921","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s00428-005-0147-4","article-title":"Multihormonality and entrapment of islets in pancreatic endocrine tumors","volume":"448","author":"Kapran","year":"2006","journal-title":"Virchows Arch"},{"key":"R121-20230921","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00428-010-0985-6","article-title":"Glucagon expression in cystic pancreatic neuroendocrine neoplasms: an immunohistochemical analysis","volume":"458","author":"Konukiewitz","year":"2011","journal-title":"Virchows Arch"},{"key":"R122-20230921","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1200\/JCO.2002.10.030","article-title":"Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups","volume":"20","author":"Hochwald","year":"2002","journal-title":"J Clin Oncol"},{"key":"R123-20230921","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.suc.2014.02.010","article-title":"Nonfunctional pancreatic neuroendocrine tumors","volume":"94","author":"Kuo","year":"2014","journal-title":"Surg Clin North Am"},{"key":"R124-20230921","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.surg.2012.08.038","article-title":"Small, nonfunctioning, asymptomatic pancreatic neuroendocrine tumors (PNETs): role for nonoperative management","volume":"152","author":"Lee","year":"2012","journal-title":"Surgery"},{"key":"R125-20230921","doi-asserted-by":"crossref","first-page":"9512","DOI":"10.3748\/wjg.v21.i32.9512","article-title":"Non-functional neuroendocrine tumors of the pancreas: advances in diagnosis and management","volume":"21","author":"Cloyd","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R126-20230921","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.surg.2015.05.042","article-title":"Resection of primary tumor site is associated with prolonged survival in metastatic nonfunctioning pancreatic neuroendocrine tumors","volume":"159","author":"Keutgen","year":"2016","journal-title":"Surgery"},{"key":"R127-20230921","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/ajg.2009.747","article-title":"Clinicopathological features of pancreatic endocrine tumors: a prospective multicenter study in Italy of 297 sporadic cases","volume":"105","author":"Zerbi","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R128-20230921","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4253\/wjge.v9.i4.153","article-title":"Non-functioning pancreatic neuroendocrine tumors: surgery or observation?","volume":"9","author":"Bar-Moshe","year":"2017","journal-title":"World J Gastrointest Endosc"},{"key":"R129-20230921","doi-asserted-by":"crossref","first-page":"R275","DOI":"10.1530\/EJE-15-0972","article-title":"GEP-NETS UPDATE: genetics of neuroendocrine tumors","volume":"174","author":"Crona","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"R130-20230921","first-page":"182","article-title":"Molecular pathology of pancreatic neuroendocrine tumors","volume":"3","author":"Chen","year":"2012","journal-title":"J Gastrointest Oncol"},{"key":"R131-20230921","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/PAP.0b013e3182169916","article-title":"Endocrine tumors as part of inherited tumor syndromes","volume":"18","author":"Zhang","year":"2011","journal-title":"Adv Anat Pathol"},{"key":"R132-20230921","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/PPO.0b013e31827459b6","article-title":"Pathology and molecular genetics of pancreatic neoplasms","volume":"18","author":"Wood","year":"2012","journal-title":"Cancer J"},{"key":"R133-20230921","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/cncr.23648","article-title":"Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies","volume":"113","author":"Jensen","year":"2008","journal-title":"Cancer"},{"key":"R134-20230921","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13053-017-0069-6","article-title":"Hereditary pancreatic cancer: related syndromes and clinical perspective","volume":"15","author":"Carrera","year":"2017","journal-title":"Hered Cancer Clin Pract"},{"key":"R135-20230921","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.soc.2015.06.007","article-title":"Hereditary pancreatic cancer syndromes","volume":"24","author":"Connor","year":"2015","journal-title":"Surg Oncol Clin N Am"},{"key":"R136-20230921","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.tem.2006.09.004","article-title":"Menin and its interacting proteins: elucidation of menin function","volume":"17","author":"Balogh","year":"2006","journal-title":"Trends Endocrinol Metab"},{"key":"R137-20230921","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/332085a0","article-title":"Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma","volume":"332","author":"Larsson","year":"1988","journal-title":"Nature"},{"key":"R138-20230921","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2796.2009.02115.x","article-title":"Multiple endocrine neoplasia type 1: a chromatin writer\u2019s block","volume":"266","author":"Dreijerink","year":"2009","journal-title":"J Intern Med"},{"key":"R139-20230921","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/ncpendmet0292","article-title":"Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation","volume":"2","author":"Dreijerink","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"R140-20230921","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/hmg\/6.7.1177","article-title":"Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1","volume":"6","author":"Lemmens","year":"1997","journal-title":"Hum Mol Genet"},{"key":"R141-20230921","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/ajco.12046","article-title":"Multiple endocrine neoplasia type 1 (MEN1)","volume":"9","author":"Carroll","year":"2013","journal-title":"Asia Pac J Clin Oncol"},{"key":"R143-20230921","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1146\/annurev.med.58.100305.115303","article-title":"The multiple endocrine neoplasia syndromes","volume":"58","author":"Lakhani","year":"2007","journal-title":"Annu Rev Med"},{"key":"R144-20230921","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R145-20230921","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1001\/archinte.1989.00390120069014","article-title":"Screening for the multiple endocrine neoplasia syndrome type I. A study of 11 kindreds in the Netherlands","volume":"149","author":"Vasen","year":"1989","journal-title":"Arch Intern Med"},{"key":"R146-20230921","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1097\/00000478-199611000-00009","article-title":"Immunohistochemical study of 100 pancreatic tumors in 28 patients with multiple endocrine neoplasia, type I","volume":"20","author":"Le Bodic","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"R147-20230921","first-page":"1","article-title":"Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study","volume":"2","author":"Chiloiro","year":"2017","journal-title":"Endocrine"},{"key":"R148-20230921","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bpg.2012.12.003","article-title":"Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances","volume":"26","author":"Ito","year":"2012","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R149-20230921","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.soc.2015.06.008","article-title":"Multiple endocrine neoplasia: genetics and clinical management","volume":"24","author":"Norton","year":"2015","journal-title":"Surg Oncol Clin N Am"},{"key":"R150-20230921","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/01.pas.0000194044.01104.25","article-title":"Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome","volume":"30","author":"Anlauf","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R151-20230921","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s00423-001-0274-6","article-title":"Timing and extent of surgery in symptomatic and asymptomatic neuroendocrine tumors of the pancreas in MEN 1","volume":"386","author":"\u00c5kerstr\u00f6m","year":"2002","journal-title":"Langenbecks Arch Surg"},{"key":"R152-20230921","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4297\/najms.2011.3164","article-title":"Pancreatic endocrine tumors","volume":"3","author":"Andr\u00e9n-Sandberg","year":"2011","journal-title":"N Am J Med Sci"},{"key":"R153-20230921","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.pan.2017.07.196","article-title":"Prognostic value of WHO grade in pancreatic neuro-endocrine tumors in multiple endocrine neoplasia type 1: results from the DutchMEN1 Study Group","volume":"17","author":"Conemans","year":"2017","journal-title":"Pancreatology"},{"key":"R154-20230921","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000217604","article-title":"Are there prognostic factors related to recurrence in pancreatic endocrine tumors?","volume":"10","author":"Casadei","year":"2010","journal-title":"Pancreatology"},{"key":"R155-20230921","first-page":"17","article-title":"Diagnosis and treatment of multiple endocrine neoplasia type 1 (MEN1)","volume":"38","author":"Gaztambide","year":"2013","journal-title":"Minerva Endocrinol"},{"key":"R156-20230921","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/ejhg.2010.175","article-title":"von Hippel-Lindau disease: a clinical and scientific review","volume":"19","author":"Maher","year":"2011","journal-title":"Eur J Hum Genet"},{"key":"R157-20230921","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/B978-0-444-62702-5.00010-X","article-title":"Von Hippel-Lindau disease","volume":"132","author":"Chittiboina","year":"2015","journal-title":"Handb Clin Neurol"},{"key":"R158-20230921","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.3109\/00365521.2015.1022211","article-title":"Pancreatic neuroendocrine tumors in von Hippel-Lindau disease","volume":"50","author":"De Mestier","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"R159-20230921","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/jjco\/hyl052","article-title":"Von Hippel-Lindau disease: molecular pathological basis, clinical criteria, genetic testing, clinical features of tumors and treatment","volume":"36","author":"Shuin","year":"2006","journal-title":"Jpn J Clin Oncol"},{"key":"R160-20230921","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","article-title":"von Hippel-Lindau disease","volume":"361","author":"Lonser","year":"2003","journal-title":"Lancet"},{"key":"R161-20230921","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.2214\/ajr.162.5.8165988","article-title":"Pancreatic lesions in von Hippel-Lindau disease: prevalence, clinical significance, and CT findings","volume":"162","author":"Hough","year":"1994","journal-title":"AJR Am J Roentgenol"},{"key":"R162-20230921","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1053\/gast.2000.18143","article-title":"Pancreatic involvement in von Hippel-Lindau disease. The Groupe Francophone d\u2019Etude de la Maladie de von Hippel-Lindau","volume":"119","author":"Hammel","year":"2000","journal-title":"Gastroenterology"},{"key":"R163-20230921","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.surg.2007.09.012","article-title":"Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs)","volume":"142","author":"Blansfield","year":"2007","journal-title":"Surgery"},{"key":"R164-20230921","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1067\/msy.1998.91823","article-title":"Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: diagnostic and management recommendations","volume":"124","author":"Libutti","year":"1998","journal-title":"Surgery"},{"key":"R165-20230921","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1067\/msy.2000.110239","article-title":"Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel-Lindau disease","volume":"128","author":"Libutti","year":"2000","journal-title":"Surgery"},{"key":"R166-20230921","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archinte.1976.03630070017007","article-title":"Von Hippel-Lindau Disease: clinical and pathological manifestations in nine families with 50 affected members","volume":"136","author":"Horton","year":"1976","journal-title":"Arch Intern Med"},{"key":"R167-20230921","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF00427365","article-title":"Von Hippel-Lindau\u2019s disease, syringomyelia and multiple endocrine tumors: a complex neuroendocrinopathy","volume":"378","author":"Probst","year":"1978","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"R168-20230921","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0002-9343(84)90450-9","article-title":"Metastatic islet cell tumor in von Hippel-Lindau disease","volume":"77","author":"Cornish","year":"1984","journal-title":"Am J Med"},{"key":"R169-20230921","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00428-013-1465-6","article-title":"Inhibin-expressing clear cell neuroendocrine tumor of the ampulla: an unusual presentation of von Hippel-Lindau disease","volume":"463","author":"Gucer","year":"2013","journal-title":"Virchows Arch"},{"key":"R170-20230921","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/SLA.0000000000000856","article-title":"Long-term prognosis of resected pancreatic neuroendocrine tumors in von hippel-lindau disease is favorable and not influenced by small tumors left in place","volume":"262","author":"De Mestier","year":"2015","journal-title":"Ann Surg"},{"key":"R171-20230921","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0140-6736(03)13166-2","article-title":"Von Recklinghausen\u2019s neurofibromatosis: neurofibromatosis type 1","volume":"361","author":"Reynolds","year":"2003","journal-title":"Lancet"},{"key":"R172-20230921","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrc3911","article-title":"A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor","volume":"15","author":"Ratner","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"R173-20230921","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/gim.2016.169","article-title":"Phenotypic predictors and final diagnoses in patients referred for RASopathy testing by targeted next-generation sequencing","volume":"19","author":"Bhoj","year":"2017","journal-title":"Genet Med"},{"key":"R174-20230921","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1542\/peds.105.3.608","article-title":"Use of the National Institutes of Health Criteria for diagnosis of neurofibromatosis 1 in children","volume":"105","author":"DeBella","year":"2000","journal-title":"Pediatrics"},{"key":"R175-20230921","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1055\/s-0036-1579766","article-title":"Neurofibromatosis: a review of NF1, NF2, and Schwannomatosis","volume":"5","author":"Kresak","year":"2016","journal-title":"J Pediatr Genet"},{"key":"R176-20230921","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2017.4","article-title":"Neurofibromatosis type 1","volume":"3","author":"Gutmann","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"R177-20230921","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/pde.12673","article-title":"Mosaic neurofibromatosis type 1: a systematic review","volume":"33","author":"Garc\u00eda-Romero","year":"2016","journal-title":"Pediatr Dermatol"},{"key":"R178-20230921","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/jso.2930590116","article-title":"Von recklinghausen\u2019s disease associated with duodenal somatostatinoma: contrast of duodenal versus pancreatic somatostatinomas","volume":"59","author":"Mao","year":"1995","journal-title":"J Surg Oncol"},{"key":"R179-20230921","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1677\/ERC-08-0142","article-title":"Are neuroendocrine tumours a feature of tuberous sclerosis? A systematic review","volume":"16","author":"Dworakowska","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"R180-20230921","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr Neurol"},{"key":"R181-20230921","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.pedhc.2006.05.004","article-title":"Tuberous sclerosis complex: a review","volume":"21","author":"Leung","year":"2007","journal-title":"J Pediatr Health Care"},{"key":"R182-20230921","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.3928\/19382359-20170320-01","article-title":"Tuberous sclerosis complex: a review","volume":"46","author":"Randle","year":"2017","journal-title":"Pediatr Ann"},{"key":"R183-20230921","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/PAS.0b013e31823d0560","article-title":"Well-differentiated pancreatic neuroendocrine carcinoma in tuberous sclerosis-case report and review of the literature","volume":"36","author":"Arva","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R184-20230921","first-page":"477","article-title":"Metastasizing gastrinoma and tuberous sclerosis complex. Association or coincidence?","volume":"139","author":"Schwarzkopf","year":"1994","journal-title":"Zentralbl Pathol"},{"key":"R185-20230921","first-page":"1543","article-title":"The association between tuberous sclerosis and insulinoma","volume":"16","author":"Kim","year":"1995","journal-title":"AJNR Am J Neuroradiol"},{"key":"R186-20230921","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4158\/EP.8.2.109","article-title":"Insulinoma in a patient with tuberous sclerosis: is there an association?","volume":"8","author":"Eledrisi","year":"2002","journal-title":"Endocr Pract"},{"key":"R187-20230921","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1136\/jnnp.55.12.1209","article-title":"Insulinoma complicating tuberous sclerosis","volume":"55","author":"Davoren","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R188-20230921","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1002\/ajmg.a.31351","article-title":"Extensive acrochordons and pancreatic islet-cell tumors in tuberous sclerosis associated with TSC2 mutations","volume":"140","author":"Merritt","year":"2006","journal-title":"Am J Med Genet A"},{"key":"R189-20230921","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s004310051073","article-title":"Malignant pancreatic tumour within the spectrum of tuberous sclerosis complex in childhood","volume":"158","author":"Verhoef","year":"1999","journal-title":"Eur J Pediatr"},{"key":"R190-20230921","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1097\/00000478-200310000-00012","article-title":"Malignant pancreatic endocrine tumor in a child with tuberous sclerosis","volume":"27","author":"Francalanci","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R191-20230921","doi-asserted-by":"crossref","first-page":"E783","DOI":"10.1210\/jc.2014-4405","article-title":"Glucagon cell hyperplasia and neoplasia with and without glucagon receptor mutations","volume":"100","author":"Sipos","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"R192-20230921","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1210\/jc.2008-1300","article-title":"Glucagon cell adenomatosis: a newly recognized disease of the endocrine pancreas","volume":"94","author":"Henopp","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R193-20230921","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/MPA.0b013e3181b2bb03","article-title":"Homozygous P86S mutation of the human glucagon receptor is associated with hyperglucagonemia, alpha cell hyperplasia, and islet cell tumor","volume":"38","author":"Zhou","year":"2009","journal-title":"Pancreas"},{"key":"R194-20230921","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3748\/wjg.v17.i2.137","article-title":"Pathologic pancreatic endocrine cell hyperplasia","volume":"17","author":"Ouyang","year":"2011","journal-title":"World J Gastroenterol"},{"key":"R195-20230921","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3390\/diagnostics5020119","article-title":"Neuroendocrine carcinomas of the gastroenteropancreatic system: a comprehensive review","volume":"5","author":"Ilett","year":"2015","journal-title":"Diagnostics"},{"key":"R196-20230921","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1002\/cncr.28721","article-title":"Gastroenteropancreatic high-grade neuroendocrine carcinoma","volume":"120","author":"Sorbye","year":"2014","journal-title":"Cancer"},{"key":"R197-20230921","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/PAS.0000000000000169","article-title":"Poorly differentiated neuroendocrine carcinomas of the pancreas: a clinicopathologic analysis of 44 cases","volume":"38","author":"Basturk","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R198-20230921","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/bjc.2016.229","article-title":"Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study","volume":"115","author":"Vijayvergia","year":"2016","journal-title":"Br J Cancer"},{"key":"R199-20230921","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2152\/jmi.51.146","article-title":"The p16INK4a-RB pathway: molecular link between cellular senescence and tumor suppression","volume":"51","author":"Ohtani1","year":"2004","journal-title":"J Med Invest"},{"key":"R200-20230921","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/PAS.0b013e3182417d36","article-title":"Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors","volume":"36","author":"Yachida","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R201-20230921","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ctrv.2017.04.002","article-title":"Unraveling molecular pathways of poorly differentiated neuroendocrine carcinomas of the gastroenteropancreatic system: a systematic review","volume":"56","author":"Girardi","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"R202-20230921","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1530\/ERC-14-0410","article-title":"Microsatellite unstable gastrointestinal neuroendocrine carcinomas: a new clinicopathologic entity","volume":"22","author":"Sahnane","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"R203-20230921","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s00535-014-0987-2","article-title":"Does the WHO 2010 classification of pancreatic neuroendocrine neoplasms accurately characterize pancreatic neuroendocrine carcinomas?","volume":"50","author":"Hijioka","year":"2015","journal-title":"J Gastroenterol"},{"key":"R204-20230921","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3322\/canjclin.35.1.2","article-title":"Cancer of the exocrine pancreas: the pathologic aspects","volume":"35","author":"Cubilla","year":"1985","journal-title":"CA Cancer J Clin"},{"key":"R205-20230921","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s00428-002-0751-5","article-title":"Mixed ductal-endocrine carcinomas of the pancreas and ductal adenocarcinomas with scattered endocrine cells: characterization of the endocrine cells","volume":"442","author":"Ohike","year":"2003","journal-title":"Virchows Arch"},{"key":"R207-20230921","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s004280050447","article-title":"Mixed ductal-endocrine carcinoma of the pancreas presenting as gastrinoma with Zollinger-Ellison syndrome: an autopsy case with a 24-year survival period","volume":"435","author":"Terada","year":"1999","journal-title":"Virchows Arch"},{"key":"R208-20230921","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1046\/j.1365-2559.2002.01447.x","article-title":"Mixed ductal-pancreatic polypeptide-cell carcinoma of the pancreas","volume":"41","author":"Chatelain","year":"2002","journal-title":"Histopathology"},{"key":"R209-20230921","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/S0046-8177(88)80240-5","article-title":"Mucinous islet cell (amphicrine) carcinoma of the pancreas associated with watery diarheaand hypokalemia syndrome","volume":"19","author":"Ord\u00f3\u00f1ez","year":"1988","journal-title":"Hum Pathol"},{"key":"R210-20230921","first-page":"449","article-title":"Mixed exocrine-endocrine tumor of the pancreas","volume":"6","author":"Ballas","year":"2005","journal-title":"JOP"},{"key":"R211-20230921","first-page":"9","article-title":"Mixed ductal-endocrine carcinoma of pancreas","volume":"2","author":"Ahmad","year":"2011","journal-title":"BMJ Case Rep"},{"key":"R212-20230921","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s12022-016-9432-9","article-title":"Mixed neuroendocrine-nonneuroendocrine neoplasms (MiNENs): unifying the concept of a heterogeneous group of neoplasms","volume":"27","author":"La Rosa","year":"2016","journal-title":"Endocr Pathol"},{"key":"R213-20230921","first-page":"233","article-title":"Pancreatic neuroendocrine tumors: update on the new World Health Organization classification","volume":"22","author":"Kl\u00f6ppel","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R214-20230921","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/pin.12255","article-title":"Ductulo-insular pancreatic endocrine tumor with amyloid deposition: report of a case","volume":"65","author":"Shintaku","year":"2015","journal-title":"Pathol Int"},{"key":"R215-20230921","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s12022-016-9454-3","article-title":"TERT promoter mutation in an aggressive cribriform morular variant of papillary thyroid carcinoma","volume":"28","author":"Oh","year":"2017","journal-title":"Endocr Pathol"},{"key":"R216-20230921","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/1097-0142(20001201)89:11<2230::AID-CNCR11>3.0.CO;2-X","article-title":"Neuroendocrine-like differentiation in patients with pancreatic carcinoma","volume":"89","author":"Tezel","year":"2000","journal-title":"Cancer"},{"key":"R217-20230921","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0344-0338(96)80071-9","article-title":"Neuroendocrine differentiation in pancreatic duct carcinoma special emphasis on duct-endocrine cell carcinoma of the pancreas","volume":"192","author":"Kamisawa","year":"1996","journal-title":"Pathol Res Pract"},{"key":"R218-20230921","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00000478-200304000-00005","article-title":"Ductulo-insular pancreatic endocrine neoplasms: clinicopathologic analysis of a unique subtype of pancreatic endocrine neoplasms","volume":"27","author":"Deshpande","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R219-20230921","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/00000478-199408000-00002","article-title":"Mixed acinar-endocrine carcinomas of the pancreas","volume":"18","author":"Klimstra","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"R220-20230921","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1097\/PAS.0b013e318263209d","article-title":"Clinicopathologic study of 62 acinar cell carcinomas of the pancreas: insights into the morphology and immunophenotype and search for prognostic markers","volume":"36","author":"La Rosa","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R221-20230921","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/PCR.0b013e3181ffb18f","article-title":"Mixed acinar-endocrine carcinoma of the pancreas","volume":"15","author":"Ohike","year":"2010","journal-title":"Pathol Case Rev"},{"key":"R222-20230921","doi-asserted-by":"crossref","first-page":"6481","DOI":"10.1186\/1757-1626-2-6481","article-title":"Mixed acinar-endocrine carcinoma of the pancreas: a case report and review of the literature","volume":"2","author":"Kyriazi","year":"2009","journal-title":"Cases J"},{"key":"R223-20230921","first-page":"20","article-title":"Mixed acinar-neuroendocrine carcinoma of the pancreas with neuroendocrine predominance","volume":"1","author":"Ogbonna","year":"2013","journal-title":"Case Rep Med"},{"key":"R224-20230921","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.2147\/OTT.S87406","article-title":"Mixed acinar-endocrine carcinoma of pancreas: a case report and brief review of the literature","volume":"8","author":"Liu","year":"2015","journal-title":"Onco Targets Ther"},{"key":"R225-20230921","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/dc.21799","article-title":"Metastatic mixed acinar-neuroendocrine carcinoma of the pancreas to the liver: a cytopathology case report with review of the literature","volume":"41","author":"Lee","year":"2013","journal-title":"Diagn Cytopathol"},{"key":"R226-20230921","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.hpb.2016.02.992","article-title":"Mixed acinar-endocrine carcinoma of the pancreas","volume":"18","author":"Apodaca-Torrez","year":"2016","journal-title":"Int Hepato-Pancreatico-Biliary Assoc"},{"key":"R227-20230921","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000343683","article-title":"Hints to the diagnosis of mixed acinar-endocrine carcinoma on pancreatic fine-needle aspiration: avoiding a potential diagnostic pitfall","volume":"57","author":"Sullivan","year":"2013","journal-title":"Acta Cytol"},{"key":"R228-20230921","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/mpa.0b013e31804bfbd3","article-title":"Acinar cell carcinoma of the pancreas: clinical analysis of 115 patients from Pancreatic Cancer Registry Of Japan Pancreas Society","volume":"35","author":"Kitagami","year":"2007","journal-title":"Pancreas"},{"key":"R229-20230921","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1007\/s11605-008-0705-6","article-title":"Acinar cell carcinoma of the pancreas in the United States: prognostic factors and comparison to ductal adenocarcinoma","volume":"12","author":"Schmidt","year":"2008","journal-title":"J Gastrointest Surg"}],"container-title":["Advances in Anatomic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00125480-201901000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T18:17:07Z","timestamp":1695320227000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00125480-201901000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":226,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/pap.0000000000000201","relation":{},"ISSN":["1072-4109"],"issn-type":[{"value":"1072-4109","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}